期刊
BIOCHEMICAL JOURNAL
卷 479, 期 19, 页码 2115-2130出版社
PORTLAND PRESS LTD
DOI: 10.1042/BCJ20220101
关键词
-
资金
- Wellcome Trust [062376, 094409, 087961]
- MRC [MR/T010789/1]
- Cancer Research UK [C1443/A22095, C1443/A12750]
- Leukemia Lymphoma Research [11022]
- Industrial Biotechnology Catalyst (Innovate UK) [BB/M018318/1]
- Industrial Biotechnology Catalyst (BBSRC) [BB/M018318/1]
- Industrial Biotechnology Catalyst (EPSRC) [BB/M018318/1]
Claspin is a crucial protein involved in the regulation of DNA replication stress. Reduced expression of Claspin is associated with cancer development and increased susceptibility to various diseases.
Claspin is an adaptor protein required for ATR-dependent phosphorylation of CHK1 during S-phase following DNA replication stress. Claspin expression is highly variable in cancer, with low levels frequently correlating with poor patient survival. To learn more about the biological consequences of reduced Claspin expression and its effects on tumorigenesis, we investigated mice with a heterozygous knockout of the Clspn gene. Claspin haploinsufficiency resulted in reduced female fertility and a maternally inherited defect in oocyte meiosis I cell cycle progression. Furthermore, aged Clspn+/- mice devel-oped spontaneous lymphoid hyperplasia and increased susceptibility to non-alcoholic fatty liver disease. Importantly, we demonstrate a tumour suppressor role for Claspin. Reduced Claspin levels result in increased liver damage and tumourigenesis in the DEN model of hepatocellular carcinoma. These data reveal that Clspn haploinsufficiency has widespread unanticipated biological effects and establishes the importance of Claspin as a regulatory node controlling tumorigenesis and multiple disease aetiologies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据